logo-loader
RNS
Tate & Lyle PLC

Tate & Lyle PLC - Form 8 (OPD) (TATE & LYLE PLC)

RNS Number : 1088G
Tate & Lyle PLC
28 May 2026
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

TATE & LYLE PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

TATE & LYLE PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

     The latest practicable date prior to the disclosure

26 May 2026

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 29 1/6 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

     TOTAL:

Nil

0

Nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b)        Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Ordinary shares of 29 1/6 pence each

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

3(a) Shares held by directors of Tate & Lyle plc

 

Director

Number of Tate & Lyle plc shares

Percentage of existing Tate & Lyle plc ordinary shares (445,446,940)

David Hearn

27,261

0.00%

Nick Hampton

951,816

0.21%

Sarah Kuijlaars

85,000

0.01%

John Cheung

5,000

0.00%

Kimberly Nelson[1]

6,568

0.00%

Jeff Carr

10 000

0.00%

Warren Tucker

9,944

0.00%

Cláudia Vaz de Lestapis[2]

20,000

0.00%

Steve Foots

16,100

0.00%

 

3(b) Directors' rights to subscribe to Tate & Lyle plc shares

 

Performance Share Plan

 

Director

Number of Tate & Lyle plc shares

Grant Date

Vesting Date / Release Date

Exercise Price

Nick Hampton

279,292

28 July 2023

After 31 March 2026

Nil

Nick Hampton

352,283

5 July 2024

After 31 March 2027

Nil

Nick Hampton

443,778

11 June 2025

After 31 March 2028

Nil

Sarah Kuijlaars

243,597

18 November 2024

After 31 March 2027

Nil

Sarah Kuijlaars

278,714

11 June 2025

After 31 March 2028

Nil

 

Sharesave Plan 2020

 

Director

Number of Tate & Lyle plc shares

Grant Date

Exercise Period

Exercise Price

Nick Hampton

6,043

11 December 2025

1 March 2029 - 31 August 2029

302

Sarah Kuijlaars

3,045

5 December 2024

1 March 2028 - 31 August 2028

609

 

3(c) Concert party interests

 

Concert party name

Number of Tate & Lyle plc shares

Percentage of total Tate & Lyle plc shares

J.M. Huber Corporation

75,000,000[3]

16.84%

In connection with the acquisition by Tate & Lyle plc of CP Kelco, J.M. Huber Corporation is entitled to receive up to 10 million ordinary shares in Tate & Lyle plc, subject to certain performance criteria based on Tate & Lyle's share price (to be calculated using the volume-weighted average price for the 30 trading days ending on and including 15 November 2026). The full 10 million shares will be issued if Tate & Lyle plc's share price over such period is at least £10.00, and no shares will be issued if Tate & Lyle plc's share price over such period is £8.50 or below.[4]

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c)        Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

28 May 2026

Contact name:

Victoria Barlow

 

Telephone number:

0207 257 2160

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 



[1] These shares are held via Tate & Lyle's sponsored American Depositary Receipt ("ADR") programme.

[2] These shares are held via Tate & Lyle's ADR programme.

[3] These shares are held by Huber Equity Corporation, a wholly owned subsidiary of J.M. Huber Corporation.

[4] Please refer to the announcements made by Tate & Lyle PLC on 15 June 2024 and 3 October 2024 for further details.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEXVLFLQELXBBL
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

6 min read